Orbactiv 70842-0140-03
Generic: Oritavancin
- Manufacturer
- Melinta Therapeutics, Llc
- Dosage Form
- Injection, Powder, Lyophilized, For Solution
- Route
- Intravenous
- Product Type
- Human Prescription Drug
- Marketing Start
- September 1, 2014
- Listing Expires
- December 31, 2026
- Application
- NDA206334
Need to source Orbactiv? Find it on a pharmacy-to-pharmacy marketplace at better prices.
✓ DSCSA Compliant. ✓ Verified Pharmacies Only.P2P pharmacy marketplace.
Active Ingredients
| Ingredient | Strength |
|---|---|
| Oritavancin | 400 mg/1 |
Drug Class
Lipoglycopeptide Antibacterial [EPC]Cytochrome P450 2C19 Inhibitors [MoA]Cytochrome P450 2C9 Inhibitors [MoA]
Selected Package
70842-0140-03Selected3 VIAL, GLASS in 1 CARTON (70842-140-03) / 1 INJECTION, POWDER, LYOPHILIZED, FOR SOLUTION in 1 VIAL, GLASS (70842-140-01)